RhumbLine Advisers’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

RhumbLine Advisers’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,713	Closed	-$261K	–	2838
2017 Q4	$261K	Sell	10,713 -2,060	-16%	-$39.6K	﹤0.01%	2525
2017 Q3	$236K	Buy	12,773 +751	+6%	+$13K	﹤0.01%	2658
2017 Q2	$199K	Buy	+12,022	New	+$167K	﹤0.01%	2762

RhumbLine Advisers's ENTL Position: Q1 2018 in Review

RhumbLine Advisers sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 10,713 shares — an estimated $261K sold.

RhumbLine Advisers first reported a position in ENTL in Q2 2017 and held it in 3 quarters. The position peaked at $261K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

RhumbLine Advisers reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
RhumbLine Advisers sold 10,713 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $261K.
RhumbLine Advisers first reported a position in Entellus Medical, Inc. Common Stock in Q2 2017 and held it in 3 quarters.
RhumbLine Advisers's Entellus Medical, Inc. Common Stock position peaked at $261K in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on RhumbLine Advisers's 13F filing for Q1 2018, filed 2 May 2018.